Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › GM CSF

GM CSF

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of GM CSF

28 trials tracked of GM CSF: 4 in phase 3 or 4 and 1 with published results. The most-cited published study has 278 citations.

28Trials tracked
4Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 2 Phase 3 2 Phase 2 23 Other / NA 1
  1. Phase 3 A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer Completed · 278 cited
  2. Phase 4 Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma Completed
  3. Phase 4 GM-CSF for Reversal of immunopAralysis in pediatriC sEpsis-induced MODS Study Completed
  4. Phase 3 Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma Completed
  5. Phase 2 G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients Completed
  6. Phase 2 Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers Completed
Show 22 more trials
  1. Phase 2 Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers Completed
  2. Phase 2 A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma Patients Completed
  3. Phase 2 Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF Completed
  4. Phase 2 Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast Cancer Completed
  5. Phase 2 A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma Completed
  6. Phase 2 GM-CSF for Maintenance of Prostate Cancer for Patients Responding to Taxotere Completed
  7. Phase 2 Therapy for Children With Advanced Stage Neuroblastoma Completed
  8. Phase 2 Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients Completed
  9. Phase 2 Neoadjuvant Treatment of Breast Cancer Completed
  10. Phase 2 Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax Completed
  11. Phase 2 WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL) Completed
  12. Phase 2 Cellular Immune Augmentation in Colon and Rectal Cancer Completed
  13. Phase 2 Chemotherapy Plus Vaccination to Treat Mantle Cell Lymphoma Completed
  14. Phase 2 Rituximab Plus Sargramostim (GM-CSF) In Patients With Chronic Lymphocytic Leukemia Completed
  15. Phase 2 Herceptin and GM-CSF for Metastatic Breast Cancer Completed
  16. Phase 2 A Randomized Trial of GM-CSF in Patients With ALI/ARDS Completed
  17. Phase 2 Dendritic Cell/Myeloma Fusion Vaccine for Multiple Myeloma (BMT CTN 1401) Completed
  18. Phase 2 WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation Completed
  19. Phase 2 Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer Completed
  20. Phase 2 GM-CSF, Sargramostim in Women With Recurrent Ovarian Cancer Completed
  21. Phase 2 Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation Completed
  22. N/A Anti-GD2 3F8 Monoclonal Antibody and GM-CSF for High-Risk Neuroblastoma Completed

Showing the 28 most-cited and recently-updated of 28 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.